|
Real-time Estimate
Cboe BZX
03:07:15 02/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 148.24 USD | +1.30% |
|
-0.33% | +20.81% |
| 09:51pm | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 28/08 | Warsh Takes the Stage |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 181B | - | ||||
| 1,031B | |||||
| 641B | - | - | - | ||
| 453B | |||||
| 349B | |||||
| 290B |
- Stock Market
- Stocks
- GILD Stock
- Charts Gilead Sciences, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
